Company Profile
Centogene Stock Price, News & Analysis
- Ticker:
- CNTG
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- Germany and has traded publicly in the U
Why the stock is moving
Current closing-price context is not available for CNTG.
Company overview
Business overview
Centogene is a precision medicine and rare-disease diagnostics company that combines testing, data, and patient identification. Its business sits at the intersection of diagnostics, genetics, and rare-disease discovery.
Geographic Base and Sector Classification
Centogene is headquartered in Germany and has traded publicly in the U.S. market, giving it a global diagnostics profile. It is more of a rare-disease information company than a therapeutics developer.
Business Model Characteristics
The model depends on test utilization, data services, and partnerships with life-science customers and physicians. Investors usually focus on diagnostic demand, international reach, and whether the company can turn rare-disease insight into recurring revenue.
Position Within the Biotechnology Landscape
Centogene occupies a diagnostics-and-data niche inside the broader biotech ecosystem. It is not a drug stock, but it is relevant because rare-disease identification and genomic testing support the development pathway.
Future catalysts
Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future. The business is still about whether the platform can find a durable footprint.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Centogene do?
Centogene is a precision medicine and rare-disease diagnostics company that combines testing, data, and patient identification. Its business sits at the intersection of diagnostics, genetics, and rare-disease discovery.
On which exchange is CNTG stock listed?
Centogene (CNTG) is associated with NASDAQ, Germany and has traded publicly in the U, MedTech.
What is Centogene?
Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future.
Which conditions is Centogene targeting with Centogene?
Centogene is associated with genetic disease based on its company overview and current catalyst commentary.
How does Centogene describe recent progress with Centogene?
Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future.
What future catalysts are investors watching for Centogene?
Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future. The business is still about whether the platform can find a durable footprint.